The current valuation score of Alector Inc is 6.91, ranking 281 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.47, which is -51.09% below the recent high of -0.72 and -313.20% above the recent low of -6.09.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.